Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX - Test2 - elhamkhani - TriplyDB

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX

http://www.wikidata.org/entity/Q28273812

about

Insulin-like growth factor binding proteins: a structural perspective.Separation of fast from slow anabolism by site-specific PEGylation of insulin-like growth factor I (IGF-I).A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants IPLEX administration improves motor neuron survival and ameliorates motor functions in a severe mouse model of spinal muscular atrophy.New therapeutic targets for amyotrophic lateral sclerosis.Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection.Doping in sport and exercise: anabolic, ergogenic, health and clinical issues.Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects.Insulin-like growth factor 1 receptor signaling induced by supraphysiological doses of IGF-1 in human peripheral blood lymphocytes.Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.Mecasermin in Insulin Receptor-Related Severe Insulin Resistance Syndromes: Case Report and Review of the Literature.ALSUntangled Update 1: Investigating a bug (Lyme Disease) and a drug (Iplex) on behalf of people with ALS IPLEX and the Telephone Game: The difficulty in separating myth from reality on the internet

P2860

Q30417447-EADE3DF7-8597-43CA-849A-4F5A76C85609 Q35010965-6E197EBA-4885-45B7-A60F-501CCCCC2A8B Q35800245-940EFE75-45A0-4DE8-AA9E-F5465BABBF8C Q36327383-11961871-5A7B-4BAF-BD3D-95161962DFC3 Q37816447-DA7E0CE2-63E8-46A3-B35E-A9505FBF926A Q38128225-ECDCBE17-6898-4066-9FB8-397D57562226 Q38589015-E2A1B425-D948-4F18-8C77-3C41963AC9F2 Q38729143-907AEDB6-24E2-4C80-B0B0-D8DB25287499 Q44478641-4BA91910-D965-436C-BE37-9B2E8FC269DC Q45899514-7974F4F9-D6F5-45EA-B86B-B76B2FF12A3B Q47568034-C7010759-C96C-48E2-8FF6-D01C8DA29696 Q52563288-3E19ECEE-B5B1-4028-8CF0-B826309822BA Q58125227-BDDCDB45-277F-494C-9B10-1DACF7373003 Q58307250-07126ECF-CA3C-4D9A-BEDE-8DD00682B7FF

P2860

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX

http://www.wikidata.org/entity/Q28273812

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX

@ast

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX

@en

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX

@nl

type

label

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX

@ast

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX

@en

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX

@nl

prefLabel

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX

@ast

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX

@en

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX

@nl

P1433

Q28273812-271E01FB-87E7-42BB-897A-762DEE758292

P1476

Q28273812-3C65ADAD-47FC-4D0D-AA47-B62920B5D1AB

P2093

Q28273812-51169D21-E8E3-4863-A7F5-80A043307CEC

Q28273812-80B3DA50-244E-407A-9793-C7B8A74DE76C

Q28273812-D8C032A1-B9BF-4B43-91AA-A0D2FCC29034

P2860

Q28273812-0144C12B-7CCA-4FE3-A918-442530159611

Q28273812-029967BB-517E-4EF2-93C4-82AA40BDEADB

Q28273812-066E4500-FB13-417A-A4DC-002AB163193B

Q28273812-0792537D-D73C-4A9A-A587-E8D8260E2081

Q28273812-0AD6536B-C3A6-4725-BB96-978C371FEF74

Q28273812-1506697A-113D-44E5-B86A-4BBA61E658C8

Q28273812-191578B2-759E-450E-B185-ED0B1363A1AE

Q28273812-1D3B9878-C04F-4DFC-A1F9-6C8CF60020DA

Q28273812-24EB229F-4B7A-47C0-949D-5AF414D4F95F

Q28273812-2E27738E-FD17-431A-9B8A-F7677B1E6033

P304

Q28273812-33124C7E-BB27-4910-8AC0-EAAEAA35830A

P31

Q28273812-4B6E64EF-17B5-45A9-B3CF-05E082A8DC35

P356

Q28273812-3E5A86E9-292C-4711-B35C-D2494BCF796A

P407

Q28273812-0D6E216C-91F4-4C6C-8804-AFE85DEE64CF

P433

Q28273812-3E307991-46AD-400F-91B3-798A40587258

P478

Q28273812-EC01E0EF-FE3E-4F5C-8513-1830FD6B7536

P50

Q28273812-918B2D0D-7E48-470D-8000-35C8CBC369C7

P577

Q28273812-E4366194-1CA6-4F97-B141-A70711F58AD0

P698

Q28273812-8317B444-4B86-4960-976A-154192A8CE04

P356

17425255.4.3.311

P1433

Expert Opinion on Drug Metabolism & Toxicology

P1476

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX

@en

P2093

Anna McDonald

http://www.w3.org/2001/XMLSchema#string

Martin O'Savage

http://www.w3.org/2001/XMLSchema#string

Rachel M Williams

http://www.w3.org/2001/XMLSchema#string

P2860

Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity

Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Cellular actions of the insulin-like growth factor binding proteins

Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling

Role of insulin-like growth factors in embryonic and postnatal growth

Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms.

Circulating levels of IGF-1 directly regulate bone growth and density.

Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors.

Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor.

P304

311-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425255.4.3.311

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

David B. Dunger

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18363546

http://www.w3.org/2001/XMLSchema#string